Treating Paralysis By Targeting The Inhibitory CSPG Molecule - Dr Kwok | Zooming In

Our ambassador Bel Young speaks to Dr Jessica Kwok about treatments for chronic spinal cord injury, looking at how chondroitin sulfate proteoglycans (CSPGs) prevent new connections being formed in the injured spinal cord and the research aiming to overcome it.
Dr Jessica Kwok is Associate Professor at the University of Leeds specialising in neuronal plasticity in spinal cord injury.
00:00 Introduction
0:20 Research during lockdown
0:37 Upbringing and scientific background
1:19 Involvement with Spinal Research
2:45 Current area of research
7:00 Long term injury treatment
8:20 Progress of treatment
9:42 Fundraising and awareness
Please visit our website to find out more: www.spinal-research.org
For more information on current human clinical trials relevant to your injury level, visit: www.scitrials.org

[@jacquelinekilbreth9085]

I am anxious to see the results of NervGen's studies with a peptide that targets the CSPG molecule going on in Chicago now.

[@nicosmind3]

It'd be great if some of these studies could get to human trials, also if some studies would look at thorasic. I know a neck break is worse, but if youre incomplete with a neck break you often have more than someone whos complete with a back break

[@SpinalResearch]

Hi there, thank you for your comment.
We are currently funding various clinical trials (using human participants), which you can find out about on our website.
To find out more about current clinical trials, particularly those relevant to your level of injury, visit the Scitrials website (link is in the description).
If you have any more questions please do not hesitate to ask.

[@Lemoncare]

Hello, thank you. Is the a medication to yank off these proteins ?